These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 1382157

  • 1. Alpha-adrenergic and angiotensin II pressor sensitivity in hypertensive patients treated with an angiotensin-converting enzyme inhibitor.
    Rosendorff C, Patton J, Radford HM, Kalliatakis B.
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S105-9. PubMed ID: 1382157
    [Abstract] [Full Text] [Related]

  • 2. Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.
    Kleinbloesem CH, Erb K, Essig J, Breithaupt K, Belz GG.
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):309S-315S. PubMed ID: 2527544
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular pressor reactivity after chronic converting enzyme inhibition.
    Bernasconi M, Marone C, Beretta-Piccoli C, Lepori G, Shaw S, Weidmann P.
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):348-55. PubMed ID: 1829371
    [Abstract] [Full Text] [Related]

  • 4. Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex.
    Belz GG, Essig J, Kleinbloesem CH, Hoogkamer JF, Wiegand UW, Wellstein A.
    Br J Clin Pharmacol; 1988 Nov; 26(5):547-56. PubMed ID: 2974715
    [Abstract] [Full Text] [Related]

  • 5. Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.
    Gasic S, Heinz G, Kleinbloesem C, Korn A.
    Br J Clin Pharmacol; 1989 Nov; 27 Suppl 2(Suppl 2):225S-234S. PubMed ID: 2548552
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic and pharmacodynamic interactions between the ACE inhibitor cilazapril and beta-adrenoceptor antagonist propranolol in healthy subjects and in hypertensive patients.
    Belz GG, Essig J, Erb K, Breithaupt K, Hoogkamer JF, Kneer J, Kleinbloesem CH.
    Br J Clin Pharmacol; 1989 Nov; 27 Suppl 2(Suppl 2):317S-322S. PubMed ID: 2527545
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.
    Sánchez RA, Traballi CA, Barclay CA, Gilbert HB, Muscará M, Giannone C, Moledo LI.
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319
    [Abstract] [Full Text] [Related]

  • 9. Renal effects of angiotensin II in normotensive subjects on short-term cilazapril treatment.
    Hannedouche T, Ikeni A, Marques LP, Natov S, Dechaux M, Schmitt F, Lacour B, Grünfeld JP.
    J Cardiovasc Pharmacol; 1992 Feb; 19 Suppl 6():S25-7. PubMed ID: 1382161
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of single and consecutive doses of cilazapril and its depressor effects in patients with essential hypertension.
    Shionoiri H, Gotoh E, Miyakawa T, Takasaki I, Oda H, Ueda S, Kaneko Y.
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):269S-273S. PubMed ID: 2970854
    [Abstract] [Full Text] [Related]

  • 11. Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7).
    Benter IF, Diz DI, Ferrario CM.
    Hypertension; 1995 Dec; 26(6 Pt 2):1138-44. PubMed ID: 7498984
    [Abstract] [Full Text] [Related]

  • 12. The effects of the long-acting angiotensin-converting enzyme inhibitor cilazapril on casual, exercise, and ambulatory blood pressure.
    White WB, McCabe EJ, Hager WD, Schulman P.
    Clin Pharmacol Ther; 1988 Aug; 44(2):173-8. PubMed ID: 2969315
    [Abstract] [Full Text] [Related]

  • 13. The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension.
    Ajayi AA, Elliott HL, Reid JL.
    Br J Clin Pharmacol; 1986 Aug; 22(2):167-75. PubMed ID: 3019375
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of the area postrema in the modulation of the baroreflex control of heart rate by angiotensin II.
    Matsukawa S, Reid IA.
    Circ Res; 1990 Dec; 67(6):1462-73. PubMed ID: 2245506
    [Abstract] [Full Text] [Related]

  • 17. Importance of endogenous angiotensin II in the cardiovascular responses to sympathetic stimulation in conscious rabbits.
    Isaacson JS, Reid IA.
    Circ Res; 1990 Mar; 66(3):662-71. PubMed ID: 2407370
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Does the combination of cilazapril and propranolol lower blood pressure at rest and during exercise more pronouncedly than either of the two components given alone?
    Erb KA, Breithaupt K, Kleinbloesem CH, Wolf GK, Belz GG.
    Clin Physiol Biochem; 1990 Mar; 8 Suppl 2():35-45. PubMed ID: 2151315
    [Abstract] [Full Text] [Related]

  • 20. Renin-angiotensin modulation of sympathetic reflex function in essential hypertension and in the elderly.
    Ajayi AA, Reid JL.
    Int J Clin Pharmacol Res; 1988 Mar; 8(5):327-33. PubMed ID: 2852643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.